• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经口幽门肌切开术(POP)治疗药物难治性胃轻瘫:高容量中心前 100 例患者的短期结果。

Per-oral Pyloromyotomy (POP) for Medically Refractory Gastroparesis: Short Term Results From the First 100 Patients at a High Volume Center.

机构信息

Section of Surgical Endoscopy, Department of General Surgery Cleveland Clinic, Cleveland, OH.

Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH.

出版信息

Ann Surg. 2018 Sep;268(3):421-430. doi: 10.1097/SLA.0000000000002927.

DOI:10.1097/SLA.0000000000002927
PMID:30004920
Abstract

OBJECTIVE

For patients with gastroparesis, temporary pyloric disruption has been shown to improve symptoms and gastric emptying. Per-oral pyloromyotomy (POP) is an innovative endoscopic procedure to divide the pylorus from within a submucosal tunnel, as a corollary to surgical pyloromyotomy. Here we evaluate subjective and objective outcomes 12-weeks after POP at a high volume center.

METHODS

The first 100 consecutive patients undergoing POP were included, with procedure dates between January 2016 and October 2017. Patients were evaluated using the Gastroparesis Cardinal Symptom Index (GCSI), and 4-hour solid-phase scintigraphic gastric emptying studies (GES) prior to procedure and at 90 days post-POP RESULTS:: The study cohort was 85% female with a mean age of 45.0 ± 14.6 years. Gastroparesis etiologies were divided among idiopathic (56%), diabetic (21%), postsurgical (19%), and other in 4%. There were 67% of the patients who had previous endoscopic or surgical interventions for gastroparesis. Most POP procedures were performed in the operating room (97%) and were completed in an average of 33 minutes. Ten patients incurred complications (10%), which included 1 diagnostic laparoscopy and 2 cases of gastrointestinal bleeding. Overall GCSI improved from a preoperative mean of 3.82 ± 0.86 to 2.54 ± 1.2 (P < 0.001). The improvement in each GCSI subscore was also highly statistically significant. Among the patients with postoperative GES available, 78% had objectively better 4-hour emptying with a mean improvement in retention by 23.6% (P < 0.001). This included 57% of patients with normal gastric emptying post-POP.

CONCLUSION

For patients with medically refractory gastroparesis, POP results in both subjective and objective improvement in the majority of patients. Prior intervention does not obviate POP as a therapeutic option. POP should be included along the treatment algorithm for patients with gastroparesis as an organ-sparing procedure.

摘要

目的

对于胃轻瘫患者,暂时破坏幽门已被证明可以改善症状和胃排空。经口幽门肌切开术(POP)是一种创新的内镜手术,通过黏膜下隧道从内部分割幽门,作为外科幽门肌切开术的推论。在这里,我们在一个高容量中心评估了 POP 后 12 周的主观和客观结果。

方法

纳入了 2016 年 1 月至 2017 年 10 月期间进行 POP 的前 100 例连续患者。在术前和 POP 后 90 天,使用胃轻瘫卡特尔症状指数(GCSI)和 4 小时固相闪烁胃排空研究(GES)对患者进行评估。

结果

研究队列中 85%为女性,平均年龄为 45.0±14.6 岁。胃轻瘫的病因分为特发性(56%)、糖尿病(21%)、手术后(19%)和其他(4%)。有 67%的患者曾因胃轻瘫接受过内镜或手术干预。大多数 POP 手术在手术室进行(97%),平均耗时 33 分钟。有 10 名患者发生并发症(10%),包括 1 例诊断性腹腔镜检查和 2 例胃肠道出血。总体 GCSI 从术前的 3.82±0.86 改善至 2.54±1.2(P<0.001)。每个 GCSI 子评分的改善也具有高度统计学意义。在术后 GES 可用的患者中,78%的患者 4 小时排空有客观改善,平均潴留减少 23.6%(P<0.001)。这包括 57%的患者在 POP 后胃排空正常。

结论

对于药物难治性胃轻瘫患者,POP 可使大多数患者的主观和客观症状均得到改善。既往干预并不能排除 POP 作为一种治疗选择。POP 应作为一种保留器官的手术,被纳入胃轻瘫的治疗方案中。

相似文献

1
Per-oral Pyloromyotomy (POP) for Medically Refractory Gastroparesis: Short Term Results From the First 100 Patients at a High Volume Center.经口幽门肌切开术(POP)治疗药物难治性胃轻瘫:高容量中心前 100 例患者的短期结果。
Ann Surg. 2018 Sep;268(3):421-430. doi: 10.1097/SLA.0000000000002927.
2
Safety and Feasibility of Per-Oral Pyloromyotomy as Augmentative Therapy after Prior Gastric Electrical Stimulation for Gastroparesis.经口幽门肌切开术作为胃轻瘫胃电刺激后的补充治疗的安全性和可行性。
J Am Coll Surg. 2019 Dec;229(6):589-595. doi: 10.1016/j.jamcollsurg.2019.09.014. Epub 2019 Oct 11.
3
Real-time intraoperative functioning lumen imaging probe during endoscopic per-oral pyloromyotomy (pop).实时内窥经口幽门肌切开术中的功能腔内腔镜成像探头 (pop)。
Surg Endosc. 2022 Jan;36(1):745-752. doi: 10.1007/s00464-020-08237-5. Epub 2021 Jan 11.
4
Per oral endoscopic pyloromyotomy for refractory gastroparesis: initial results from a single institution.经口内镜下幽门肌切开术治疗难治性胃轻瘫:单中心初步结果。
Surg Endosc. 2017 Dec;31(12):5381-5388. doi: 10.1007/s00464-017-5619-5. Epub 2017 May 31.
5
Laparoscopic pyloroplasty versus endoscopic per-oral pyloromyotomy for the treatment of gastroparesis.腹腔镜幽门成形术与经口内镜下肌切开术治疗胃轻瘫的比较。
Surg Endosc. 2019 Mar;33(3):773-781. doi: 10.1007/s00464-018-6342-6. Epub 2018 Jul 17.
6
Endoscopic findings do not predict per-oral pyloromyotomy (POP) response.内镜检查结果无法预测经口幽门肌切开术(POP)的疗效。
Surg Endosc. 2023 Feb;37(2):1384-1391. doi: 10.1007/s00464-022-09321-8. Epub 2022 May 24.
7
Per-Oral Pyloromyotomy (POP) for Medically Refractory Post-Surgical Gastroparesis.经口幽门肌切开术(POP)治疗药物难治性术后胃轻瘫。
J Gastrointest Surg. 2019 Jun;23(6):1095-1103. doi: 10.1007/s11605-018-04088-7. Epub 2019 Feb 26.
8
Gastroparesis with concomitant gastrointestinal dysmotility is not a contraindication for per-oral pyloromyotomy (POP).伴有胃肠动力障碍的胃轻瘫不是经口幽门肌切开术(POP)的禁忌证。
Surg Endosc. 2022 Jun;36(6):4226-4232. doi: 10.1007/s00464-021-08756-9. Epub 2021 Oct 12.
9
Per oral pyloromyotomy utilizing a lesser curvature approach: how we do it.经口幽门肌切开术采用小弯侧入路:我们的方法。
Surg Endosc. 2020 Nov;34(11):5168-5171. doi: 10.1007/s00464-020-07802-2. Epub 2020 Jul 14.
10
[S156] Comparing outcomes of per-oral pyloromyotomy and robotic pyloroplasty for the treatment of gastroparesis.比较经口幽门肌切开术和机器人幽门成形术治疗胃轻瘫的疗效。
Surg Endosc. 2023 Mar;37(3):2247-2252. doi: 10.1007/s00464-022-09437-x. Epub 2022 Jul 28.

引用本文的文献

1
Pyloric Dysfunction: A Review of the Mechanisms, Diagnosis, and Treatment.幽门功能障碍:机制、诊断与治疗综述
Gut Liver. 2025 May 15;19(3):327-345. doi: 10.5009/gnl240421. Epub 2025 Mar 10.
2
Outcomes after per oral pyloromyotomy based on gastroparesis etiology.基于胃轻瘫病因的经口幽门肌切开术后的结局
Surg Endosc. 2025 Feb;39(2):1114-1119. doi: 10.1007/s00464-024-11468-5. Epub 2024 Dec 19.
3
A long-term follow-up study of gastric peroral endoscopic myotomy (G-POEM) in a large cohort of patients with postsurgical gastroparesis.
对大量胃轻瘫术后患者进行经口内镜下胃肌切开术(G-POEM)的长期随访研究。
Surg Endosc. 2024 Dec;38(12):7416-7425. doi: 10.1007/s00464-024-11184-0. Epub 2024 Oct 24.
4
Initial experience and outcomes of per oral pyloromyotomy for the treatment of refractory gastroparesis.经口幽门肌切开术治疗难治性胃轻瘫的初步经验和结果。
Surg Endosc. 2024 Nov;38(11):6778-6781. doi: 10.1007/s00464-024-11178-y. Epub 2024 Aug 19.
5
Invasive acupuncture for gastroparesis after thoracic or abdominal surgery: a systematic review and meta-analysis.经胸或腹部手术后胃轻瘫的侵入性针灸治疗:系统评价和荟萃分析。
BMJ Open. 2023 Jun 26;13(6):e068559. doi: 10.1136/bmjopen-2022-068559.
6
Gastric peroral endoscopic pyloromyotomy (G-POEM) in patients with refractory gastroparesis: a review.难治性胃轻瘫患者的经口内镜下幽门肌切开术(G-POEM):综述
Therap Adv Gastroenterol. 2023 Mar 26;16:17562848231151289. doi: 10.1177/17562848231151289. eCollection 2023.
7
Predictors of favorable outcome after pyloroplasty for gastroparesis: should response to pyloric dilation or Botox injection be used as a marker of surgical outcome?胃轻瘫行幽门成形术后结局良好的预测因素:幽门扩张或肉毒杆菌素注射的反应是否可作为手术结局的标志物?
Surg Endosc. 2023 Jun;37(6):4360-4369. doi: 10.1007/s00464-023-09882-2. Epub 2023 Feb 7.
8
Targeting the pylorus in gastroparesis: From physiology to endoscopic pyloromyotomy.针对胃轻瘫的幽门:从生理学到内镜幽门肌切开术。
Neurogastroenterol Motil. 2023 Feb;35(2):e14529. doi: 10.1111/nmo.14529. Epub 2023 Jan 3.
9
Efficacy and safety of endoscopic pyloric balloon dilation in patients with refractory gastroparesis.内镜下幽门球囊扩张治疗难治性胃轻瘫的疗效和安全性。
Surg Endosc. 2022 Nov;36(11):8012-8020. doi: 10.1007/s00464-022-09230-w. Epub 2022 Apr 18.
10
POEM, GPOEM, and ZPOEM.经自然腔道内镜手术(POEM)、经胃黏膜下隧道内镜肿瘤切除术(GPOEM)和经黏膜下隧道内镜肿瘤切除术(ZPOEM)。
Dig Dis Sci. 2022 May;67(5):1500-1520. doi: 10.1007/s10620-022-07398-8. Epub 2022 Apr 2.